A clinical trial run by DTU's Translational Research Group (TRG) has featured in the local media in the hope that it encourages people to take part.
Funded by the British Heart Foundation, the study aims to find out if changing the way we give aspirin to people with type 2 diabetes could help protect them from heart attacks and strokes.
TRG are looking for volunteers in the Oxfordshire area who have diabetes, but do not have heart disease, to take part in the study. DTU Deputy Director Dr Angelyn Bethel featured in the Oxford Mail article, explaining more about the trial and how people can get involved.
To read the Oxford Mail article, see http://www.oxfordmail.co.uk/news/9713208.Diabetes_pill_trial_seeks_volunteers/
To find out more about the group and the trial, read our latest bulletin at